Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements

Reproductive Toxicology

Volumn 33, Issue 4, 2012, Pages 419-427

  Raymer, James H ^a   Michael, Larry C ^a   Studabaker, William B ^a   Olsen, Geary W ^b   Sloan, Carol S ^a   Wilcosky, Timothy ^c   Walmer, David K ^d  

^a RTI INTERNATIONAL   (United States)

^b 3M COMPANY   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hormones; Perfluorinated chemicals; PFOA; PFOS; Plasma; Semen quality

Indexed keywords

ESTRADIOL; FOLLITROPIN; LIOTHYRONINE; LUTEINIZING HORMONE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE;

ABSTINENCE; AGE DISTRIBUTION; ARTICLE; BLOOD LEVEL; CELL PH; CELL VOLUME; HORMONE DETERMINATION; HUMAN; HUMAN CELL; MALE; REPRODUCTIVE TOXICITY; SEMEN ANALYSIS; SEMINAL PLASMA; SMOKING HABIT; SPERMATOGENESIS; SPERMATOZOON MOTILITY; TOXICITY TESTING; VISCOSITY;

ALKANESULFONIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; NORTH CAROLINA; OCTANOIC ACIDS; SEMEN; SPERM COUNT; SPERM MOTILITY; TANDEM MASS SPECTROMETRY; THYROID HORMONES;

NICOTIANA TABACUM;

EID: 84861526898     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.05.024     Document Type: Article

References (31)

1. Paul A.G., Jones K.C., Sweetman A.J. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 2009, 43:386-392.
2. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 2006, 40:32-43.
3. Trudel D., Horowitz L., Wormuth M., Scheringer M., Cousins I.T., Hungerbuhler K. Estimating consumer exposure to PFOS and PFOA. Risk Anal 2008, 28:251-269.
4. U.S. EPA (Environmental Protection Agency). 2010/2015 PFOA Stewardship Program Homepage. 2010; Available from: Accessed December 16, 2010. http://www.epa.gov/oppt/pfoa/pubs/stewardship/index.html.
5. Kato K, Wong LY, Lily T, Zsuzsanna K, Calafat AM. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 2011; doi:10.1021/es1043613.
6. Haug L.S., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 2009, 43(6):2131-2136.
7. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., Boyd T.M., et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 2008, 42:4989-4995.
8. Spliethoff H.M., Tao L., Shaver S.M., Aldous K.M., Pass K.A., Kannan K., et al. Use of newborn screening program blood spots for exposure assessment: declining levels of perfluorinated compounds in New York State infants. Environ Sci Technol 2008, 42:5361-5367.
9. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 99:366-394.
10. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 2009, 27:212-230.
11. Joensen U.N., Bossi R., Leffers H., Jensen A.A., Skakkebaek N.E. Do perfluoroalkyl compounds impact human semen quality?. Environ Health Perspect 2009, 117:923-927.
12. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005, 215:126-148.
13. Butenhoff J.L., Kennedy G.L., Frame S.R., O'Connor J.C., York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 2004, 196:95-116.
14. York R.G., Kennedy G.L., Olsen G.W., Butenhoff J.L. Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. Toxicology 2010, 271:64-72.
15. World Health Organization. WHO laboratory manual for the examination and processing of human semen, 5th ed. Geneva, Switzerland: World Health Organization Press; 2010.
16. Meachem S.J., Nieschlage E., Simoni M. Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 2001, 145:561-571.
17. Seacat A.M., Thomford P.J., Hasne K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 2002, 68:249-264.
18. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 2003, 74:369-381.
19. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 2003, 74:382-392.
20. Chang S.C., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J.A., Froehlich J.W., et al. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorocotanesulfoante (PFOS). Toxicology 2007, 234:21-33.
21. Lopez-Espinosa M.J., Fitz-Simon N., Bloom M.S., Clafat A.M., Fletcher T. Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfoante and perfluoroctanoate. Repro Toxicol 2012, 33:552-555.
22. Chang S.C., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J.A., Froehlich J.W., et al. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 2008, 243:330-339.
23. Dallaire R., Dewailly E., Pereg D., Dery S., Ayotte P. Thyroid function and plasma concentrations of polyhalogenated compounds in inuit adults. Environ Health Perspect 2009, 117(9):1380-1386.
24. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Epidemiologic assessment of worker serum perfluoroctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 2003, 45:260-270.
25. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 2007, 81:231-246.
26. Costa G., Sartori S., Consonni D. Thirty years of medical surveillance in perfluorooctanoic acid production workers. J Occup Environ Med 2009, 51:364-372.
27. Olsen G.W., Gilliland F.D., Burlew M.M., Burris M.P.H., Jean M., Mandel J.S., et al. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998, 40:614-622.
28. Sakr C.J., Kreckman K.H., Green J.W., Gillies P.J., Reynolds J.L., Leonard R.C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 2007, 49:1086-1096.
29. Biegel L.B., Liu R.C.M., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol 1995, 134:18-25.
30. Perkins R.G., Butenhoff J.L., Kennedy G.L., Palazzol M.J. 13-Week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats. Drug Chem Toxicol 2004, 27:361-378.
31. Longnecker M.P., Smith C.S., Kissling G.E., Hoppin J.A., Butenhoff J.L., Decker E., et al. An interlaboratory study of perfluorinated alkyl compound levels in human plasma. Environ Res 2008, 107(2):152-159.